Other studies demonstrated increased RNA expression of CLU, a calcium binding protein, in peripheral blood from MS patients (Razia et al., 2022) and increased protein levels in cerebrospinal fluid (van Luijn et al., 2016). The gene discussed is CLU; the disease is myeloid sarcoma.